Recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing NCT06066138 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
